RELATIONSHIP OF METABOLIC SYNDROME COMPONENTS WITH ELECTROCARDIOGRAPHIC BIOMARKERS OF METABOLIC CARDIOMYOPATHY IN MEN WITH CORONARY ATHEROSCLEROSIS

RELATIONSHIP OF METABOLIC SYNDROME COMPONENTS WITH ELECTROCARDIOGRAPHIC BIOMARKERS OF METABOLIC CARDIOMYOPATHY IN MEN WITH CORONARY ATHEROSCLEROSIS

Aim. To study electrocardiographic (ECG) markers of metabolic cardiomyopathy (MC) and their association with the components and markers of metabolic syndrome (MS) in men with coronary atherosclerosis (CA). Material and methods. Totally 77 men included at the age 42-77 with stenotic CA verified by co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. I. Ragino, N. A. Timoshenko, A. M. Chernjavskyi, S. Yu. Tcimbal, L. V. Scherbakova, M. I. Voevoda
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-04-01
Series:	Российский кардиологический журнал
Subjects:	electrocardiographicbiomarkers metaboliccardiomyopathy coronary atherosclerosis metabolic syndrome
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/286
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ASSOCIATION OF ELECTROCARDIOGRAPHIC MARKERS OF METABOLIC CARDIOMYOPATHY WITH LONG-TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN MEN WITH CORONARY ATHEROSCLEROSIS
by: N. A. Timoshenko, et al.
Published: (2014-06-01)

ASSOCIATION OF BIOMOLECULES OF SECRETORY ACTIVITY OF VISCERAL ADIPOCYTES WITH ELECTROPHYSIOLOGICAL SIGNS OF METABOLIC DISORDERS OF MYOCARDIUM IN CORONARY ATHEROSCLEROSIS AND METABOLIC SYNDROME
by: Yu. I. Ragino, et al.
Published: (2017-06-01)

HIGH PREVALENCE OF METABOLIC SYNDROME IN SIBERIAN MEN WITH CORONARY ATHEROSCLEROSIS
by: M. I. Voevoda, et al.
Published: (2010-02-01)

THE ASSESSMENT OF BIOMARKER COMPLEX IN MEN WITH CORONARY ATHEROSCLEROSIS
by: E. V. Kashtanova, et al.
Published: (2016-02-01)

BLOOD LIPID AND NON-LIPID BIOMARKERS IN NOVOSIBIRSK MEN WITH CORONARY ATHEROSCLEROSIS
by: Yu. I. Ragino, et al.
Published: (2009-04-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

Levels of metalloproteinases and adipose tissue hormones in men with coronary atherosclerosis
by: Ya. V. Polonskaya, et al.
Published: (2024-01-01)

GENETIC MARKERS OF METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN YAKUTIA INHABITANTS
by: А. N. Romanova, et al.
Published: (2017-11-01)

INFLAMMATORY CYTOCINES GENES POLYMORPHISM ASSOCIATION WITH SERUM LEVELS OF BIOCHEMICAL MARKERS AT THE CORONARY ATHEROSCLEROSIS
by: A. V. Shevchenko, et al.
Published: (2014-08-01)

Lipid and lipoprotein disturbances in coronary atherosclerosis: comparison with general populaD tion data
by: M. I. Voevoda, et al.
Published: (2005-08-01)

Modern methods for studying atherosclerosis and coronary artery disease: flow cytometry
by: E. M. Stakhneva, et al.
Published: (2021-07-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Role of fatty acids in inflammation, atherosclerosis, metabolic disorders and gout
by: M. A. Gromova, et al.
Published: (2021-12-01)

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis
by: M. V. Klimushina, et al.
Published: (2016-11-01)

APPROACHES TO THE LIPID METABOLISM GENES POLYMORPHYSM ANALYSIS IN SCREENING FOR ATHEROSCLEROSIS RISK FACTORS
by: N. V. Koch, et al.
Published: (2014-10-01)

Glucose Metabolism Reprogramming of Vascular Endothelial Cells and Its Implication in Development of Atherosclerosis
by: Shiwen Luo, et al.
Published: (2024-11-01)

ENDOTOXINEMIA AND ATHEROSCLEROSIS
by: Y. S. Schwarz, et al.
Published: (2001-08-01)

Unfavorable variants of folate metabolism genes in patients with acute coronary syndrome in non-obstructive coronary atherosclerosis
by: V. V. Ryabov, et al.
Published: (2018-11-01)

Alterations in the Salivary Microbiome and Metabolism in Patients With Carotid Atherosclerosis from Rural Northeast China
by: Yahong Wu, et al.
Published: (2024-08-01)

Value of proprotein convertase subtilisin/kexin type 9 and inflammatory markers in the diagnosis of carotid atherosclerosis in hypertensive men
by: Yu. Yu. Vukolova, et al.
Published: (2024-10-01)

Hepatokine and Proinflammatory Cytokine Profile in Patients with Carotid Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Ana Delfina Cano-Contreras, et al.
Published: (2025-04-01)

Heqi San alleviates diabetic atherosclerosis and alters serum metabolic profiles in rats
by: Shufang Chu, et al.
Published: (2025-08-01)

Metabolic and epigenetic regulation of macrophage polarization in atherosclerosis: Molecular mechanisms and targeted therapies
by: Pinglian Yang, et al.
Published: (2025-02-01)

Abnormal lipid metabolism and atherosclerosis: a new perspective on organelle function regulation and ferroptosis
by: Xize Wu, et al.
Published: (2025-08-01)

EPICARDIAL OBESITY AND A RANGE OF METABOLIC RISK FACTORS RELATION WITH THE PREVALENCE INDEX OF CORONARY ATHEROSCLEROSIS
by: G. A. Chumakova, et al.
Published: (2015-04-01)

CORONARY ATHEROSCLEROSIS FACTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND METABOLIC SYNDROME
by: T. V. Krovyakova, et al.
Published: (2010-06-01)

Association between Metabolic Syndrome Score and Subclinical Atherosclerosis
by: Ming Yi, et al.
Published: (2025-03-01)

Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis
by: Julie Gall, et al.
Published: (2016-12-01)

Evalution of Inhibin B and some Sexual Hormones Levels in men with Atherosclerosis Kirkuk city
by: Layla Abd-Al-Sattar Sadiq Laylani
Published: (2023-01-01)

ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice
by: Monika Svecla, et al.
Published: (2024-11-01)

Identification of lipid metabolism related immune markers in atherosclerosis through machine learning and experimental analysis
by: Hang Chen, et al.
Published: (2025-02-01)

Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism
by: Dan Li, et al.
Published: (2025-03-01)

Cytokines are the Basis of the Development and Suppression of Inflammation in Atherosclerosis
by: Alexander V. Blagov, et al.
Published: (2025-03-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
by: V. V. Kukharchuk, et al.
Published: (2020-06-01)

NEW DIRECTIONS IN ATHEROSCLEROSIS PHARMACOTHERAPY
by: S. V. Dutova, et al.
Published: (2017-12-01)

Hyperlipidemia and atherosclerosis: experimental models
by: K. I. Davletova, et al.
Published: (2025-07-01)

Features of metabolic disorders in the patients with diseases associated with atherosclerosis, on the background of functional bile outflow abnormalities
by: I. A. Gorbacheva, et al.
Published: (2014-03-01)

PREDICTION OF MULTIFOCAL ATHEROSCLEROSIS IN WOMEN WITH RHEUMATOID ARTHRITIS
by: I. V. Osipova, et al.
Published: (2018-06-01)

Electrocardiographic markers of proarrhythmogenicity in metabolic syndrome
by: S. Kitov, et al.
Published: (2025-05-01)

Systemic lupus erythematosus and atherosclerosis: immune pathways and the uncharted territory of gut microbiota and metabolism
by: Quanren Pan, et al.
Published: (2025-04-01)